Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia

Schreiner, Andreas; Aadamsoo, Kaire; Altamura, A.; Franco, Manuel; Gorwood, Philip; Neznanov, Nikolaj; SCHRONEN, Juan; Ucok, Vehbi; ZINK, Mathias; JANIK, Adam; CHERUBIN, Pierre; LAHAYE, Marjolein; HARGARTER, Ludger

doi:10.1016/j.schres.2015.08.015

Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia

Copy For Citation

Schreiner A., Aadamsoo K., Altamura A. C., Franco M., Gorwood P., Neznanov N. G., ...More

SCHIZOPHRENIA RESEARCH, vol.169, pp.393-399, 2015 (SCI-Expanded)

Publication Type: Article / Article
Volume: 169
Publication Date: 2015
Doi Number: 10.1016/j.schres.2015.08.015
Journal Name: SCHIZOPHRENIA RESEARCH
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
Page Numbers: pp.393-399
Istanbul University Affiliated: Yes

Abstract

Objective: Relapse and acute exacerbation are common in schizophrenia and may impact treatment response and outcome. Evidence is conflicting in respect to superiority of long-acting injectable antipsychotic therapies versus oral antipsychotics in relapse prevention. This randomized controlled study assessed the efficacy of paliperidone palmitate versus oral antipsychotics for relapse prevention.